OrthoPediatrics (NASDAQ:KIDS) Trading Down 3.5% Following Insider Selling

OrthoPediatrics Corp. (NASDAQ:KIDS) dropped 3.5% on Wednesday following insider selling activity. The stock traded as low as $24.48 and last traded at $24.54. Approximately 22,235 shares were traded during trading, a decline of 86% from the average daily volume of 162,242 shares. The stock had previously closed at $25.42.

Specifically, insider Gregory A. Odle sold 5,359 shares of the company’s stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $24.86, for a total transaction of $133,224.74. Following the transaction, the insider now directly owns 148,788 shares of the company’s stock, valued at $3,698,869.68. This represents a 3.48 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Fred Hite sold 6,443 shares of the company’s stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $24.86, for a total value of $160,172.98. Following the transaction, the chief financial officer now directly owns 207,989 shares in the company, valued at approximately $5,170,606.54. The trade was a 3.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In other news, CEO David R. Bailey sold 6,620 shares of the company’s stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $24.86, for a total transaction of $164,573.20. Following the transaction, the chief executive officer now directly owns 319,155 shares of the company’s stock, valued at $7,934,193.30. This represents a 2.03 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.

Analyst Upgrades and Downgrades

A number of analysts recently commented on KIDS shares. Stifel Nicolaus reduced their price objective on OrthoPediatrics from $40.00 to $32.00 and set a “buy” rating for the company in a research report on Wednesday, March 5th. Needham & Company LLC reiterated a “buy” rating and set a $42.00 price objective on shares of OrthoPediatrics in a research report on Wednesday, March 5th. Finally, Truist Financial reduced their price objective on OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating for the company in a research report on Wednesday, December 18th.

OrthoPediatrics Stock Performance

The company has a debt-to-equity ratio of 0.19, a current ratio of 7.17 and a quick ratio of 3.68. The business has a 50-day moving average of $24.79 and a 200 day moving average of $25.53. The company has a market cap of $610.82 million, a PE ratio of -20.45 and a beta of 1.22.

OrthoPediatrics (NASDAQ:KIDS) last issued its quarterly earnings results on Tuesday, March 4th. The company reported ($0.29) EPS for the quarter, topping analysts’ consensus estimates of ($0.33) by $0.04. The business had revenue of $52.67 million during the quarter, compared to analysts’ expectations of $51.16 million. OrthoPediatrics had a negative return on equity of 5.78% and a negative net margin of 15.00%. During the same quarter in the prior year, the business posted ($0.23) earnings per share. Equities research analysts anticipate that OrthoPediatrics Corp. will post -0.93 EPS for the current fiscal year.

Institutional Trading of OrthoPediatrics

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Wellington Management Group LLP increased its position in OrthoPediatrics by 16.2% in the third quarter. Wellington Management Group LLP now owns 883,221 shares of the company’s stock worth $23,944,000 after buying an additional 122,846 shares in the last quarter. Barclays PLC grew its position in shares of OrthoPediatrics by 319.3% during the third quarter. Barclays PLC now owns 25,298 shares of the company’s stock worth $686,000 after purchasing an additional 19,264 shares in the last quarter. Geode Capital Management LLC grew its position in shares of OrthoPediatrics by 2.1% during the third quarter. Geode Capital Management LLC now owns 391,492 shares of the company’s stock worth $10,615,000 after purchasing an additional 7,972 shares in the last quarter. Mutual of America Capital Management LLC grew its position in shares of OrthoPediatrics by 195.1% during the third quarter. Mutual of America Capital Management LLC now owns 107,609 shares of the company’s stock worth $2,917,000 after purchasing an additional 71,146 shares in the last quarter. Finally, Centiva Capital LP purchased a new stake in shares of OrthoPediatrics during the third quarter worth about $319,000. Hedge funds and other institutional investors own 69.05% of the company’s stock.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.